A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer

Inclusion Criteria

• •1. Participants aged over 18 years
• •2. Participants who have a history of gastric and duodenal ulcer falling under the approved indication for Pariet Tablet 5 mg and who are receiving Pariet Tablet 5 mg to prevent gastric and duodenal ulcer from low dose aspirin use of 100 mg or less daily
• •3. Participants whose prescription of Pariet Tablet 5 mg has been determined before study participation
• •4. Participants who have given written consent to the use of their personal and medical information